ADEMPA 10 mg contains Riociguat, a soluble guanylate cyclase (sGC) stimulator, indicated for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It works by enhancing the nitric oxide pathway, leading to vasodilation of the pulmonary arteries, reducing pulmonary vascular resistance and improving exercise capacity and quality of life.